Literature DB >> 28009070

Effects of aripiprazole and haloperidol on neural activation during a simple motor task in healthy individuals: A functional MRI study.

Rhianna Goozee1, Owen O'Daly2, Rowena Handley3, Tiago Reis Marques1, Heather Taylor1, Grant McQueen1, Kathryn Hubbard1, Carmine Pariante4,5, Valeria Mondelli4,5, Antje A T S Reinders1, Paola Dazzan1,5.   

Abstract

The dopaminergic system plays a key role in motor function and motor abnormalities have been shown to be a specific feature of psychosis. Due to their dopaminergic action, antipsychotic drugs may be expected to modulate motor function, but the precise effects of these drugs on motor function remain unclear. We carried out a within-subject, double-blind, randomized study of the effects of aripiprazole, haloperidol and placebo on motor function in 20 healthy men. For each condition, motor performance on an auditory-paced task was investigated. We entered maps of neural activation into a random effects general linear regression model to investigate motor function main effects. Whole-brain imaging revealed a significant treatment effect in a distributed network encompassing posterior orbitofrontal/anterior insula cortices, and the inferior temporal and postcentral gyri. Post-hoc comparison of treatments showed neural activation after aripiprazole did not differ significantly from placebo in either voxel-wise or region of interest analyses, with the results above driven primarily by haloperidol. We also observed a simple main effect of haloperidol compared with placebo, with increased task-related recruitment of posterior cingulate and precentral gyri. Furthermore, region of interest analyses revealed greater activation following haloperidol compared with placebo in the precentral and post-central gyri, and the putamen. These diverse modifications in cortical motor activation may relate to the different pharmacological profiles of haloperidol and aripiprazole, although the specific mechanisms underlying these differences remain unclear. Evaluating healthy individuals can allow investigation of the effects of different antipsychotics on cortical activation, independently of either disease-related pathology or previous treatment. Hum Brain Mapp 38:1833-1845, 2017.
© 2017 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  antipsychotic; functional neuroimaging; motor; schizophrenia

Mesh:

Substances:

Year:  2016        PMID: 28009070      PMCID: PMC6867001          DOI: 10.1002/hbm.23485

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  57 in total

Review 1.  Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study.

Authors:  M J Cuesta; V Peralta; A Zarzuela
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

2.  Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.

Authors:  N Tzourio-Mazoyer; B Landeau; D Papathanassiou; F Crivello; O Etard; N Delcroix; B Mazoyer; M Joliot
Journal:  Neuroimage       Date:  2002-01       Impact factor: 6.556

3.  A rating scale for extrapyramidal side effects.

Authors:  G M Simpson; J W Angus
Journal:  Acta Psychiatr Scand Suppl       Date:  1970

4.  Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction.

Authors:  James A Waltz; Michael J Frank; Benjamin M Robinson; James M Gold
Journal:  Biol Psychiatry       Date:  2007-02-14       Impact factor: 13.382

5.  Subcortical overactivation in untreated schizophrenic patients: a functional magnetic resonance image finger-tapping study.

Authors:  Jürgen L Müller; Christian Röder; Gerhardt Schuierer; Helmfried E Klein
Journal:  Psychiatry Clin Neurosci       Date:  2002-02       Impact factor: 5.188

6.  Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients.

Authors:  D F Braus; G Ende; W Weber-Fahr; A Sartorius; A Krier; P Hubrich-Ungureanu; M Ruf; S Stuck; F A Henn
Journal:  Schizophr Res       Date:  1999-08-23       Impact factor: 4.939

7.  The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy.

Authors:  P F Liddle
Journal:  Br J Psychiatry       Date:  1987-08       Impact factor: 9.319

8.  Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain.

Authors:  Rowena Handley; Fernando O Zelaya; A A T Simone Reinders; Tiago Reis Marques; Mitul A Mehta; Ruth O'Gorman; David C Alsop; Heather Taylor; Atholl Johnston; Steve Williams; Philip McGuire; Carmine M Pariante; Shitij Kapur; Paola Dazzan
Journal:  Hum Brain Mapp       Date:  2012-03-25       Impact factor: 5.038

9.  Levodopa effects on hand and speech movements in patients with Parkinson's disease: a FMRI study.

Authors:  Audrey Maillet; Alexandre Krainik; Bettina Debû; Irène Troprès; Christelle Lagrange; Stéphane Thobois; Pierre Pollak; Serge Pinto
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

10.  An Activation Likelihood Estimation Meta-Analysis Study of Simple Motor Movements in Older and Young Adults.

Authors:  Ted K Turesky; Peter E Turkeltaub; Guinevere F Eden
Journal:  Front Aging Neurosci       Date:  2016-10-17       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.